Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
2.560
-0.200 (-7.25%)
At close: Aug 11, 2025, 4:00 PM
2.700
+0.140 (5.47%)
After-hours: Aug 11, 2025, 4:56 PM EDT

Paramount Global Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2020
63245----
Upgrade
Enterprise Value
-67113----
Upgrade
Last Close Price
2.5610.08----
Upgrade
Debt / Equity Ratio
0.090.080.310.260.010.13
Upgrade
Asset Turnover
-0.000.280.030.02-
Upgrade
Quick Ratio
13.3215.226.454.028.364.41
Upgrade
Current Ratio
13.8415.406.534.098.414.53
Upgrade
Return on Equity (ROE)
-86.18%-54.24%-44.15%-57.84%-99.72%-286.85%
Upgrade
Return on Assets (ROA)
-41.57%-26.72%-16.10%-24.68%-33.43%-67.03%
Upgrade
Return on Capital (ROIC)
-50.15%-30.89%-23.03%-33.32%-45.02%-101.60%
Upgrade
Buyback Yield / Dilution
-2746.19%-1302.54%-4.70%-11.80%-8.60%-3.59%
Upgrade
Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q